Client of a consultant lobbyist
Centre for the Commercialization of Regenerative Medicine
- Meetings this Parliament
- 6
- With MPs
- 3
- Since Nov 2021
- 71
- Active registrations
- 1
Most recent reported meeting: Aug 26, 2026.
Lobbying by Centre for the Commercialization of Regenerative Medicine: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingWho they meet
Since the current Parliament opened.
MPs
- Karim Bardeesy Liberal 1
- John-Paul Danko Liberal 1
- Karina Gould Liberal 1
Institutions
- House of Commons3
- National Research Council (NRC)1
- National Defence (DND)1
- Innovation, Science and Economic Development Canada (ISED)1
Registrations in effect
Consultant In effect since Aug 5, 2026 Receives government funding
Consultant William Mantel
Consultant lobbyists
- William Mantel
- William Mantel
- William Mantel
Institutions they may lobby: Business Development Bank of Canada (BDC), Export Development Canada (EDC), Federal Economic Development Agency for Southern Ontario (FedDev), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), National Defence (DND), National Research Council (NRC), Prime Minister's Office (PMO), Public Services and Procurement Canada (PSPC)
What they're lobbying on (2)Hide details
- Discussing the value of the subsidiary OmniaBio, as soveriegn capacity that is critical to Canada's needs in the event of future pandemics or national emergency, leading to support from federal entitities that supply capital and other financial products.
- Continued effort to maintain strong support for strategic value of the Strategic Response Fund support for the project re the application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty.
Registration 944505-367602-15. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by William Mantel · Consultant
- Mackenzy Metcalfe · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Continued effort to maintain strong support for strategic value of the Strategic Response Fund support for the project re the application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty. Read more
-
Reported by William Mantel · Consultant
- waugh joseph · Analyst, National Defence (DND)
- Wendy Hepburn · Analyst, National Defence (DND)
Continued effort to maintain strong support for strategic value of the Strategic Response Fund support for the project re the application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty. Read more
Discussing the value of the subsidiary OmniaBio, as soveriegn capacity that is critical to Canada's needs in the event of future pandemics or national emergency, leading to support from federal entitities that supply capital and other financial products.
-
Reported by William Mantel · Consultant
- John-Paul Danko · MP
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty. Read more
-
Reported by William Mantel · Consultant
- David Lisk · Vice President, IRAP, National Research Council (NRC)
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty. Read more
-
Reported by William Mantel · Consultant
- Karim Bardeesy · MP
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty. Read more
-
Reported by William Mantel · Consultant
- Karina Gould · Leader of the Government in the House of Commons
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty. Read more
-
Reported by William Mantel · Consultant
- Anita Anand · Minister of Innovation, Sciences and Economic Development, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility. The support will result in lower cost of life saving cell and gene therapy products. Read more
-
Reported by William Mantel · Consultant
- Sean Matthew O'Neill · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Laurel Chester · Sr Advisor, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility. The support will result in lower cost of life saving cell and gene therapy products. Read more
-
Reported by William Mantel · Consultant
- Karina Gould · Member of Parliament
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility. The support will result in lower cost of life saving cell and gene therapy products. Read more
-
Reported by William Mantel · Consultant
- Eric Costen · Associate Deputy Minister, Health Canada (HC)
- Sarah Lawley · Assistant Deputy Minister, Health Canada (HC)
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility. The support will result in lower cost of life saving cell and gene therapy products. Read more
-
Reported by William Mantel · Consultant
- Nicholas Kang · Senior Policy Advisor, Prime Minister's Office (PMO)
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility. The support will result in lower cost of life saving cell and gene therapy products. Read more
-
Reported by William Mantel · Consultant
- Sean Matthew O'Neill · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility. The support will result in lower cost of life saving cell and gene therapy products. Read more
-
Reported by William Mantel · Consultant
- Eshan Naik · Director of Policy, Health Canada (HC)
Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility. The support will result in lower cost of life saving cell and gene therapy products. Read more
-
Reported by William Mantel · Consultant
- Eshan Naik · Director of Policy, Health Canada (HC)
Strategic Investment Fund Industrial Research Assistance Program National Research Council funding for advanced therapy manufacturing
-
Reported by William Mantel · Consultant
- Nicholas Kang · Senior Policy Advisor, Prime Minister's Office (PMO)
Strategic Investment Fund Industrial Research Assistance Program National Research Council funding for advanced therapy manufacturing
-
Reported by William Mantel · Consultant
- Laurel Chester · Sr Advisor, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentRegional DevelopmentScience and Technology
-
Reported by William Mantel · Consultant
- Prihar Roopa · Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Nidal Islam · A/ Deputy Director, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentRegional DevelopmentScience and Technology
-
Reported by William Mantel · Consultant
- Prihar Roopa · Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Nidal Islam · A/ Deputy Director, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentRegional DevelopmentScience and Technology
-
Reported by William Mantel · Consultant
- Laurel Chester · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentRegional DevelopmentScience and Technology
-
Reported by William Mantel · Consultant
- Prihar Roopa · Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Nidal Islam · A/ Deputy Director, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentRegional DevelopmentScience and Technology
-
Reported by William Mantel · Consultant
- Prihar Roopa · Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Nidal Islam · A/ Deputy Director, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentRegional DevelopmentScience and Technology
-
Reported by William Mantel · Consultant
- Nidal Islam · A/ Deputy Director, Innovation, Science and Economic Development Canada (ISED)
- Prihar Roopa · Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Samantha Setiawan · Financial Investment Analyst, Innovation, Science and Economic Development Canada (ISED)
- Catherine Martinelli · Business Risk Analyst, Innovation, Science and Economic Development Canada (ISED)
and 3 moreShow fewer
- Victoria Hoskin · Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Razan Shahin · Manager, Innovation, Science and Economic Development Canada (ISED)
- Katherine Sedivi-Haley · Analyst, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentRegional DevelopmentScience and Technology
-
Reported by William Mantel · Consultant
- Jean-Pierre Mizero · Manager, Innovation, Science and Economic Development Canada (ISED)
- Nidal Islam · A/ Deputy Director, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentRegional DevelopmentScience and Technology
-
Reported by William Mantel · Consultant
- Jean-Pierre Mizero · Manager, Innovation, Science and Economic Development Canada (ISED)
- Prihar Roopa · Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Catherine Martinelli · Business Risk Analyst, Innovation, Science and Economic Development Canada (ISED)
- Nidal Islam · A/ Deputy Director, Innovation, Science and Economic Development Canada (ISED)
and 1 moreShow fewer
- Razan Shahin · Manager, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentRegional DevelopmentScience and Technology
-
Reported by William Mantel · Consultant
- Antioco Puddu · Constituency Assistant, House of Commons
Economic DevelopmentRegional DevelopmentScience and Technology
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.